secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0000950170-25-096914
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics converts $1.4M of notes, issues 2.15M shares at ~$0.65 avg price
-------------------------------------------------------------------------------

- On June 20-27 and July 15, 2025, YA II PN converted $1.4M of Second and Third Notes into 2,154,530 common shares.
- Conversion prices ranged from $0.5624 to $0.6934 per share; Second Note fully converted, Third Note has $3.9M remaining.
- First Note retains full $5.0M principal; total remaining note balance across all three is $8.9M.
- Shares issued in reliance on Section 4(a)(2) exemption; no public offering involved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025096914/0000950170-25-096914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025096914/fblg-20250620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-096914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer